$0.4476
0.01363.13%
At close: Jun 26, 5:00 PM EST
$0.4470
-0.0006-0.13%
After Hours: 4:26 PM EST
Vivos Therapeutics Inc Earnings Estimates
VVOSNASDAQ
Vivos Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VVOS
Vivos Therapeutics (VVOS) is scheduled to report Q2 earnings on August 18, 2026. Analysts estimate EPS of $-0.46 and quarterly revenue of $5.61M.
In the most recent quarter (Q1), Vivos Therapeutics reported EPS of $-0.52, missing estimates of $-0.45 by 0.16%. Revenue came in at $5.14M, exceeding the estimate of $5.04M by 0.02%.
Vivos Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Vivos Therapeutics has averaged an EPS surprise of 0.22% and a revenue surprise of 0.24%.
Earnings Date
Aug 18
EPS Estimate
$-0.460
Quarterly Revenue Estimate
$5.61M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$19.57M
Vivos Therapeutics Earnings History
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Loading calendar...
Vivos Therapeutics (VVOS) Earnings Per Share
The chart below shows Vivos Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Vivos Therapeutics (VVOS) Revenue
The chart below shows Vivos Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?
Vivos Therapeutics (VVOS) is scheduled to report earnings on August 18, 2026. The last reported earnings were for reported on May 20, 2026 for Q1.
What were the latest earnings per share (EPS) for Vivos Therapeutics (NASDAQ:VVOS)?
The Actual EPS was $-0.52, which missed the estimate of $-0.45.
What were Vivos Therapeutics’s (NASDAQ:VVOS) revenues?
The Actual Revenue was $5.14M, which beat the estimate of $5.04M.
